Ruling out SARS-CoV-2 infection using exhaled breath analysis by electronic nose in a public health setting

  title={Ruling out SARS-CoV-2 infection using exhaled breath analysis by electronic nose in a public health setting},
  author={Rianne de Vries and Ren{\'e} M. Vigeveno and Sije Mulder and Niloufar Farzan and D. R. Vintges and Jelle J. Goeman and S. M. Bruisten and B. van der Corput and J. J. Miranda Geelhoed and Leo G. Visser and Mariken van der Lubben and Peter J. Sterk and Johannes C C M in 't Veen and Geert H. Groeneveld},
Background: Rapid and accurate detection of SARS-CoV-2 infected individuals is crucial for taking timely measures and minimizing the risk of further SARS-CoV-2 spread. We aimed to assess the accuracy of exhaled breath analysis by electronic nose (eNose) for the discrimination between individuals with and without a SARS-CoV-2 infection. Methods: This was a prospective real-world study of individuals presenting to public test facility for SARS-CoV-2 detection by molecular amplification tests (TMA… 

Electronic and animal noses for detecting SARS-CoV-2 infection

This protocol is a protocol for a Cochrane Review (diagnostic) to assess the diagnostic test accuracy of eNoses to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in public places, such as airports.

Recent Advances in Novel Lateral Flow Technologies for Detection of COVID-19

Recent advances in novel lateral flow technologies for detecting SARS-CoV-2 as well as innovative approaches to achieve highly sensitive and specific point-of-care testing are highlighted.

Breath Metabolites to Diagnose Infection

Characteristic and reproducible breath VOCs are associated with several infectious diseases, suggesting breath analysis as a promising strategy for diagnostic development.

Hybrid learning method based on feature clustering and scoring for enhanced COVID-19 breath analysis by an electronic nose

Volatile compounds in human breath: critical review and meta-analysis

It is demonstrated that a suite of targeted, functional volatile biomarkers, rather than individual biomarker compounds, will improve accuracy and success in diagnostic research and application.



Applying the electronic nose for pre-operative SARS-CoV-2 screening

The Aeonose can distinguish COVID-19 positive from negative participants based on VOC patterns in exhaled breath with a high NPV, and might be a promising, non-invasive, and low-cost triage tool for excluding SARS-CoV-2 infection in patients elected for surgery.

Breath biomarkers of pediatric SARS-CoV-2 infection: a pilot study

This work hypothesizes that candidate biomarkers characterize the exhaled breath of children with SARS-CoV2 infection, and provides a solid framework upon which to build a future ''breathalyzer'' test for SARS -CoV-2 infection in children.

Rapid detection of SARS-CoV-2 infection by multicapillary column coupled ion mobility spectrometry (MCC-IMS) of breath. A proof of concept study

SARS-CoV-2 infection and influenza-A infection can be detected with the help of MCC-IMS in breath in this pilot study and should be further developed in a larger cohort for screening of communicable viral diseases.

The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?

Breath analysis could allow a fast differential diagnosis between SARS-COV-2, influenza or rhinovirus infection and hospitalize those patients with proven COVID-19 disease, where other patients can easily recover at home.

Multiplexed Nanomaterial-Based Sensor Array for Detection of COVID-19 in Exhaled Breath

A noninvasive approach in detecting and following-up individuals who are at-risk or have an existing COVID-19 infection, with a potential ability to serve as an epidemic control tool and a platform that could be applied for any other disease infection with proper modifications to the artificial intelligence.

Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review

The current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2 are summarized, evaluating the advantages and drawbacks for specific tests.

Breath-borne VOC Biomarkers for COVID-19

The monitoring of ethyl butanoate, butyraldehyde and isopropanol could lend considerable support in rapidly screening CO VID-19; and alerting the presence of COVID-19 patient in particular environments.